EDITORIAL
Acute kidney injury after adult liver transplantation—Doesn’t intraoperative management matter?
Tetsuro Sakai,
Corresponding Author
Tetsuro Sakai
Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
Correspondence
Tetsuro Sakai, Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh Medical Center Montefiore, N469.4, 200 Lothrop Street, Pittsburgh, PA 15213, USA.
Email: [email protected]
Search for more papers by this author
Tetsuro Sakai,
Corresponding Author
Tetsuro Sakai
Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
Correspondence
Tetsuro Sakai, Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh Medical Center Montefiore, N469.4, 200 Lothrop Street, Pittsburgh, PA 15213, USA.
Email: [email protected]
Search for more papers by this author
First published: 05 April 2022
No abstract is available for this article.
CONFLICT OF INTEREST
Tetsuro Sakai received grants from Haemonetics Inc.
REFERENCES
- 1Wong F, Pappas SC, Curry MP, Reddy KR, Rubin RA, Porayko MK, et al. Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome. N Engl J Med. 2021; 384: 818–28.
- 2Zhou J, Zhang X, Liu L, Ma X, Miao G, Chu H. Modifiable risk factors of acute kidney injury after liver transplantation: a systematic review and meta-analysis. BMC Nephrol. 2021; 22: 149.
- 3Berkowitz RJ, Engoren MC, Mentz G, Sharma P, Kumar SS, Davis R, et al. Intraoperative risk factors of acute kidney injury following liver transplantation. Liver Transpl. 2022; 28: 1207–23.
